Novel 6-aryl-2-methylnicotinic acid hydrazides 4a-c and their corresponding hydrazones 5a-c and 6a-i were synthesized. X-ray single crystal diffraction of 6h confirmed the chemical structure of hydrazones 6a-i. Antiproliferative activity of the synthetic compounds was investigated against K562 leukemia cell lines. Variable cell growth inhibitory activities were obtained with IC50 range from 24.99 to 66.78 μM where the compound 6c exhibited the maximum activity. Structure activity relationship analysis has been performed and a common pharmacophore model for the synthesized derivatives has been obtained by using the pharmacophore elucidation module of the software MOE. The best model obtained is characterized by two projected locations of potential H-bond donors (F 3 and F4) and two Aromatic annotations (F1 and F2).
合成了新型6-芳基-2-甲基 nicotine 酸
肼(4a-c)及其对应的
肼酮(5a-c和6a-i)。对6h的X射线单晶衍射确认了
肼酮6a-i的
化学结构。合成化合物的抗增殖活性在K562白血病
细胞系上进行了研究,获得了不同的细胞生长抑制活性,IC50范围为24.99至66.78μM,其中化合物6c表现出最大的活性。进行了结构活性关系分析,并利用软件MOE的药效团阐明模块获得了合成衍
生物的共同药效团模型。获得的最佳模型具有两个潜在H键供体的投影位置(F3和F4)和两个芳香标记(F1和F2)。